SBFM
Sunshine Biopharma, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.14
+2.70%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.17
- Revenue estimate
- $9.6M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.15
- EPS estimate
- -$1.20
- Revenue actual
- $9.3M
- Revenue estimate
- $8.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -19.1%
- Revenue beats (12Q)
- 3
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026